Investigation of Sema4A as a biomarker for treatment selection for multiple sclerosis

被引：2
|
作者：
Koda, Toru [1 ]
Okuno, Tatsusada [1 ]
Nakatsujj, Yuji [1 ]
Takata, Kazushiro [1 ]
Honorat, Josephe Archie [1 ]
Namba, Akiko [1 ]
Sakoda, Saburo [2 ]
Kumanogoh, Atsushi [3 ,4 ,5 ]
Mochizuki, Hideki [1 ]
机构：
[1] Osaka Univ, Grad Sch Med, Dept Neurol, Osaka, Japan
[2] Toneyama Natl Hosp, Natl Hosp Org, Osaka, Japan
[3] Osaka Univ, Grad Sch Med, Dept Resp Med, Osaka, Japan
[4] Osaka Univ, Grad Sch Med, Dept Allergy, Osaka, Japan
[5] Osaka Univ, Grad Sch Med, Dept Rheumat Dis, Osaka, Japan
来源：
JOURNAL OF NEUROIMMUNOLOGY | 2014年 / 275卷 / 1-2期
关键词：
D O I：
10.1016/j.jneuroim.2014.08.058
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
140
引用
收藏
页码：20 / 21
页数：2
相关论文
共 50 条
  • [1] Sema4A as a biomarker for the selection of treatment of MS
    Nakatsuji, Y.
    Koda, T.
    Okuno, T.
    Miyazaki, Y.
    Niino, M.
    Fukazawa, T.
    Takata, K.
    Namba, A.
    Yamashita, K.
    Shimizu, M.
    Kinoshita, M.
    Sakoda, S.
    Kumanogoh, A.
    Mochizuki, H.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 580 - 580
  • [2] Sema4A as a biomarker for personalized therapy of multiple sclerosis
    Koda, T.
    Okuno, T.
    Nakatsuji, Y.
    Takata, K.
    Namba, A.
    Yamashita, K.
    Honorat, J. A.
    Tada, S.
    Kinoshita, M.
    Sakoda, S.
    Kumanogoh, A.
    Mochizuki, H.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 305 - 305
  • [3] The possible involvement of sema3A and sema4A in the pathogenesis of multiple sclerosis
    Eiza, N.
    Garty, M.
    Staun-Ram, E.
    Miller, A.
    Vadasz, Z.
    CLINICAL IMMUNOLOGY, 2022, 238
  • [4] Involvement of Sema4A in multiple sclerosis and neuromyelitis optica
    Okuno, Tatsusada
    Koda, Toru
    Miyamoto, Katsuichi
    Takata, Kazushiro
    Honorat, Josephe A.
    Kusunoki, Susumu
    Kumanogoh, Atsushi
    Nakatsuji, Yuji
    Mochizuki, Hideki
    JOURNAL OF NEUROIMMUNOLOGY, 2014, 275 (1-2) : 43 - 43
  • [5] Elevated serum Sema4A level in patients with multiple sclerosis
    Nakatsuji, Yuji
    Moriya, Masayuki
    Okuno, Tatsusada
    Kinoshita, Makoto
    Sugimoto, Tomoyuki
    Konomi, Ayako
    Nakano, Misa
    Kikutani, Hitoshi
    Kumanogoh, Atsushi
    Sakoda, Saburo
    JOURNAL OF NEUROIMMUNOLOGY, 2008, 203 (02) : 129 - 129
  • [6] Sema4A as a diagnostic marker and its pathogenic roles in multiple sclerosis
    Nakatsuji, Y.
    Moriya, M.
    Okuno, T.
    Kinoshita, M.
    Sugimoto, T.
    Nakano, M.
    Kikutani, H.
    Sakoda, S.
    Kumanogoh, A.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S79 - S79
  • [7] Sema4A enhances Th cell adhesion and neuroinflammation; implications for multiple sclerosis pathogensis
    Okuno, T.
    Koda, T.
    Honorat, J.
    Takata, K.
    Mochizuki, H.
    Kumanogoh, A.
    Nakatsuji, Y.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 140 - 141
  • [8] Evaluation of NEDA and clinical characteristics in multiple sclerosis patients with high serum sema4a levels
    Namba, A. H.
    Okuno, T.
    Koda, T.
    Yamashita, K.
    Shimizu, M.
    Kinoshita, M.
    Kumanogoh, A.
    Miyazaki, Y.
    Niino, M.
    Miyamoto, K.
    Nakatsuji, Y.
    Mochizuki, H.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 440 - 441
  • [9] Class IV semaphorin SEMA4A from CSF of multiple sclerosis patients induces oligodendrocyte cell death
    Chiou, B.
    Lucassen, E.
    Connor, J.
    JOURNAL OF NEUROCHEMISTRY, 2017, 142 : 250 - 250
  • [10] Sema4A is a serum diagnostic marker of Multiple Sclerosis, which reflects the TH17 shift of PBMC
    Yuji, Nakatsuji
    Tatsusada, Okuno
    Masayuki, Moriya
    Tomoyuki, Sugimoto
    Makoto, Kinoshita
    Misa, Nakano
    Hitoshi, Kikutani
    Saburo, Sakoda
    Atsushi, Kumanogoh
    JOURNAL OF NEUROIMMUNOLOGY, 2010, 228 (1-2) : 187 - 188
12345